Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients (CeTeG)

This study is currently recruiting participants.
Verified July 2012 by University Hospital, Bonn
Sponsor:
Information provided by (Responsible Party):
Ulrich Herrlinger, University Hospital, Bonn
ClinicalTrials.gov Identifier:
NCT01149109
First received: June 14, 2010
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)